24Dec 2024
Combination Therapy for Schistosomiasis Control

Combination Therapy for Schistosomiasis Control

Praziquantel alone has limitations in treating Schistosoma mansoni infections due to low efficacy against juvenile worms and potential resistance. This randomized trial in Kenyan children evaluated praziquantel combined with artemisinin-based therapies. Praziquantel plus artesunate-mefloquine (88.7% cure rate) and praziquantel plus dihydroartemisinin-piperaquine (85.7% cure rate) showed non-inferiority to praziquantel alone (82.5%). Both combinations were safe, but further multicenter trials are needed to validate these findings.

  • #critical care

Like

Save

Share